Cargando…

Newly Diagnosed Chronic Lymphocytic Leukemia During Symptomatic COVID-19: Two Cases

Patients suffering from malignant diseases have a high risk of developing severe or critical forms of COVID-19 (Coronavirus Disease 2019). Chronic lymphocytic leukaemia (CLL) is characterized by dysregulated adaptive and innate immune responses, because both T and B cells, the function of phagocytes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papp, Enikő, Tasnády, Szabolcs, Tisza, Katalin, Király, Ágnes, Bekő, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562477/ https://www.ncbi.nlm.nih.gov/pubmed/36313909

Ejemplares similares

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans
por: Vályi-Nagy, István, et al.
Publicado: (2021)

The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
por: Park, Yumi, et al.
Publicado: (2018)

Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency
por: Goda, Vera, et al.
Publicado: (2022)

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
por: Wang, Yucai, et al.
Publicado: (2021)

Quantification of newly produced B and T lymphocytes in untreated chronic lymphocytic leukemia patients
por: Motta, Marina, et al.
Publicado: (2010)

Efficacy and safety of biosimilar rituximab (ZytuxTM) in newly diagnosed patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia
por: Alwan, Alaa Fadhil, et al.
Publicado: (2020)

Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients
por: Singh, Namrata, et al.
Publicado: (2020)

Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011)

COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia
por: Kim, Chul Soo, et al.
Publicado: (2022)

Overexpression of Semaphorin-3A and Semaphorin-4D in the Peripheral Blood from Newly Diagnosed Patients with Chronic Lymphocytic Leukemia
por: Parsa, Somayeh, et al.
Publicado: (2019)

Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers
por: Kunnumbrath, Arathi, et al.
Publicado: (2022)

Pregnancy Course of 10 Women Diagnosed with Chronic Lymphocytic Leukemia
por: Tadmor, Tamar, et al.
Publicado: (2023)

Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
por: Sun, Jianai, et al.
Publicado: (2020)

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
por: Togasaki, E, et al.
Publicado: (2017)

Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study
por: Szabó, Bálint Gergely, et al.
Publicado: (2023)

A Needle in the Haystack: A Rare Case of Spontaneous Tumor Lysis in Newly Diagnosed Chronic Lymphocytic Leukemia Unmasked by Acute Renal Failure
por: Desai, Milap, et al.
Publicado: (2020)

Aetiological Features of Elderly Patients with Newly Diagnosed Symptomatic Epilepsy in Western China
por: Guo, Yi, et al.
Publicado: (2018)

Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
por: Karp, Judith E, et al.
Publicado: (2008)

Ocular Manifestations of Newly Diagnosed Acute Leukemia Patients
por: Mirshahi, Reza, et al.
Publicado: (2022)

Management of Newly Diagnosed Chronic Myeloid Leukemia During COVID-19 Hospitalization: A Teaching Case
por: Bangolo, Ayrton I, et al.
Publicado: (2022)

Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis
por: Radich, Jerald P., et al.
Publicado: (2023)

Population modeling of bosutinib exposure‐response in patients with newly diagnosed chronic phase chronic myeloid leukemia
por: Garrett, May, et al.
Publicado: (2023)

Chemokine Receptors CCR1 and CCR2 on Peripheral Blood Mononuclear Cells of Newly Diagnosed Patients with the CD38-Positive Chronic Lymphocytic Leukemia
por: Kholodnyuk, Irina, et al.
Publicado: (2020)

Two-session Radiosurgery as Initial Treatment for Newly Diagnosed Large, Symptomatic Brain Metastases from Breast and Lung Histology
por: Lovo, Eduardo E, et al.
Publicado: (2019)

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?
por: Magnano, Laura, et al.
Publicado: (2020)

The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology
por: Kastenbaum, Hannah A., et al.
Publicado: (2010)

Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature
por: Quintela, Adrien, et al.
Publicado: (2017)

Treatment strategy in chronic lymphocytic leukemia with symptomatic central nervous system involvement: A case report
por: Dewaide, Rosina, et al.
Publicado: (2023)

Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
por: Ibrahim, Ali, et al.
Publicado: (2022)

Chronic Lymphocytic Leukemia
por: Vaisitti, Tiziana, et al.
Publicado: (2020)

Chronic lymphocytic leukemia
por: Rossi, Davide
Publicado: (2018)

Regulatory and Memory B Lymphocytes in Children With Newly Diagnosed Immune Thrombocytopenia
por: Zahran, Asmaa M., et al.
Publicado: (2017)

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
por: Cortes, Jorge E., et al.
Publicado: (2018)

First-line treatment strategies for newly diagnosed chronic myeloid leukemia: a network meta-analysis
por: Chen, Kang-Kang, et al.
Publicado: (2018)

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia
por: Gambacorti-Passerini, Carlo, et al.
Publicado: (2014)

Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib
por: Gullaksen, Stein-Erik, et al.
Publicado: (2017)

Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial
por: Brümmendorf, Tim H., et al.
Publicado: (2022)

Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy
por: Migita, Kiyoshi, et al.
Publicado: (2015)

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
por: Steegmann, Juan Luis, et al.
Publicado: (2017)

T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
por: Vlachonikola, Elisavet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_47j21dsqc7tt898uklmcj76j63